Communiqués Sunshine Biopharma, Inc.

Actions

SBFM

US8677816014

Temps réel estimé Cboe BZX Autres places de cotation 19:32:33 17/07/2024			Varia. 5j.	Varia. 1 janv.
0,321 ^USD	-3,02 %		-8,31 %	-98,78 %

20/05	Sunshine Biopharma, Inc. déclare ses résultats pour le premier trimestre clos le 31 mars 2024	CI
12/04	Les actions de Sunshine Biopharma chutent après l'annonce du regroupement d'actions	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg, a Biosimilar of Neulasta	22/04	AQ
Sunshine Biopharma Announces Reverse Stock Split	15/04	AQ
Thinking about buying stock in Mediwound, AeroVironment, Airship AI, Lyell Immunopharma, or Sunshine Biopharma?	06/03	PR
Sunshine Biopharma Moves Principal Office to New York City	04/12	AQ
Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%	11/08/23	AQ
SUNSHINE BIOPHARMA, INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	16/05/23	AQ
Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-Market	16/05/23	AQ
Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market	12/05/23	AQ
SUNSHINE BIOPHARMA, INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	11/05/23	AQ
Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%	11/05/23	AQ
Sunshine Biopharma : Certificate of Incorporation/Bylaws - Form 8-K	19/04/23	PU
SUNSHINE BIOPHARMA, INC : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	19/04/23	AQ
Sunshine Biopharma Reports Full Year Ended December 31, 2022 Financial Results and Provides Corporate Update	05/04/23	AQ
SUNSHINE BIOPHARMA, INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	04/04/23	AQ
SUNSHINE BIOPHARMA, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	24/03/23	AQ
Vivakor Announces New Board of Directors	23/03/23	AQ
Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based Covid-19 Treatment	28/02/23	AQ
SUNSHINE BIOPHARMA, INC : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	28/02/23	AQ
SUNSHINE BIOPHARMA, INC : Other Events (form 8-K)	13/02/23	AQ
SUNSHINE BIOPHARMA SIGNS RESEARCH AGREEMENT WITH THE JEWISH GENERAL HOSPITAL TO ADVANCE THE DEVELOPMENT OF Adva-27a ANTICANCER COMPOUND	13/02/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Sunshine Biopharma, Inc.

Actions

SBFM

US8677816014

Communiqués

Filtres